A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathyBarbara Hutka(Semmelweis University), Zoltán Zádori(Semmelweis University)Acta Pharmacologica SinicaOctober 10, 202310.1038/s41401-023-01175-7Cited by 5SaveCiteExport RISWatch citationsRelated PapersThe Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the Rat|Frontiers in Pharmacology|2021|14Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats|Biochemical Pharmacology|2020|11